
|Articles|March 15, 2005
Generic ciprofloxacin gets FDA approval
Amityville, NY—The FDA has granted approval to Hi-Tech Pharmacal Co.'s Abbreviated New Drug Application for ciprofloxacin ophthalmic solution USP, 0.3%.
Advertisement
Amityville, NY-The FDA has granted approval to Hi-Tech Pharmacal Co.'s Abbreviated New Drug Application for ciprofloxacin ophthalmic solution USP, 0.3%.
This is the generic equivalent of Alcon Laboratories' Ciloxan Ophthalmic Solution, 0.3%, which is indicated for the treatment of bacterial infections.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
MeiraGTx Licenses complement-targeted geographic atrophy program from ZipBio
2
Metformin use associated with reduced incidence of intermediate AMD
3
Last year in glaucoma at EnVision Summit 2025
4
Looking back at the 2025 EnVision Summit
5




























